Abstract: There is provided a machine for producing an aerosol-forming composition for an aerosol-generating system, the machine including a plurality of reservoirs configured to contain components of an aerosol-forming composition; a mixing mechanism in communication with the plurality of reservoirs; a controller connected to, and configured to control, the mixing mechanism; a user interface connected to the controller for a user to operate the machine, the mixing mechanism being configured to mix selective quantities of components from the plurality of reservoirs according to specified ratios to create an aerosol-forming composition; a testing mechanism including a heater assembly configured to vaporize a test sample to form an aerosol, and at least one outlet configured to deliver the aerosol to the user; and a transfer mechanism configured to deliver the test sample to the testing mechanism. There is also provided a machine and process for producing and delivering the test sample.

Abstract: The present disclosure relates to a man-machine interface, including a steering wheel rotatably supported about a steering wheel axis and an input device attached to the steering wheel, wherein the input device includes a fingerprint sensor with an acquisition surface for acquiring a fingerprint of a finger of an operator and additionally at least one touch-sensitive and/or operation-sensitive input surface, which is disposed outside the acquisition surface and preferably spaced from the acquisition surface, with an associated detection device, and an evaluation unit connected in an electrically conductive manner with the detection device and the fingerprint sensor, wherein the evaluation unit is configured to verify the data acquired by the fingerprint sensor with a signal of the detection device and, if necessary, to discard them.

Abstract: Compounds of formula (I) are inhibitors of LMP7 and can be employed, inter alia, for the treatment of an autoimmune disorder or hematological malignancies.

Abstract: Compounds of formula (I) are inhibitors of LMP7 and can be employed, inter alia, for the treatment of an autoimmune disorder or hematological malignancies.

Abstract: An input device includes a fingerprint sensor, an operating layer having a first operating surface, at least one force sensor, and an evaluation unit. The first operating surface has an acquisition surface which acquires a fingerprint of a finger of an operator via the fingerprint sensor. The at least one force sensor measures an operating force of the finger of the operator acting on the first operating surface. The evaluation unit is electrically conductively connected with the fingerprint sensor and with the at least one force sensor. The evaluation unit assigns at least one first switching function to the operating force applied on first operating surface of the operating layer if the operating force measured on the first operating surface exceeds a first threshold value.

Abstract: A lighting system for automobiles is proposed which includes a laser light source emitting a primary laser light bundle within a solid angle area around a beam direction, a photoluminescence element positioned within the emitted primary light beam, and a protective element that protects against stray laser rays. The photoluminescence element is configured to absorb the laser rays impinging on said element and by means of the photoluminescence to radiate secondary light rays. The lighting system includes a protection system with a protective element of an elongated shape having a first end and a second end, wherein the first end of the protective element is positioned within the beam direction of the primary light beam and downstream of the photoluminescence element.

Abstract: The present invention relates to a method and device for triggering an automatic emergency braking process in a vehicle to avoid a tail-end collision with an obstacle, wherein a warning to the driver is triggered if at least one warning condition is satisfied, wherein the satisfaction of the warning condition specifies that owing to the instantaneous driving situation of the vehicle relative to the obstacle the automatic emergency braking process should be triggered, wherein the automatic emergency braking process is not triggered until after the warning to the driver is triggered and a warning time period has subsequently expired, wherein the warning time period is set as a function of the relative movement situation between the vehicle and the obstacle and/or is adapted as a function of a relative movement, which changes over time, between the vehicle and the obstacle.

Abstract: A luminous means comprising a substrate having a first main surface, to which a first electrode is applied, a second electrode, an organic layer stack within an active region of the substrate between the first and the second electrode, wherein the organic layer stack comprises at least one organic layer which is suitable for generating light, and at least one reflective element, which is formed along a main plane of the luminous means, wherein the luminous means has two operating states, such that the luminous means is an illumination source in a first operating state and the luminous means is a mirror in a second operating state.

Abstract: The present invention relates to compounds of the formula (I) and in particular to medicaments comprising at least one compound of the formula I for use in the treatment and/or prophylaxis of physiological and/or pathophysiological conditions in the triggering of which cathepsin D is involved, in particular for use in the treatment and/or prophylaxis of osteoarthritis, traumatic cartilage injuries, arthritis, pain, allodynia or hyperalgesia.

Abstract: An organic light-emitting diode comprising an organic layer sequence, a radiation exit area and an encapsulation. The organic layer sequence comprises at least one radiation-emitting region which generates electromagnetic radiation in the spectral range from infrared radiation to UV radiation during operation. The radiation exit area is structured, so that the electromagnetic radiation has a directional emission profile. The encapsulation forms a seal of the organic layer sequence against environmental influences.

Abstract: The present invention relates to compounds of the formula (I) and in particular medicaments comprising at least one compound of the formula (I) for use in the treatment and/or prophylaxis of physiological and/or pathophysiological states in the triggering of which cathepsin D is involved, in particular for use in the treatment and/or prophylaxis of arthrosis, traumatic cartilage injuries, arthritis, pain, allodynia or hyperalgesia.

Abstract: The present invention relates to pharmaceutical preparations and medicaments for intraarticular administration, comprising pepstatin, and to the preparation and use thereof, in particular in the treatment and/or prophylaxis of arthrosis, traumatic cartilage injuries, arthritis, pain, allodynia or hyperalgesia, particularly preferably in arthrosis.

Abstract: A glazing comprising a luminous means with a substrate having a first main surface, to which a first electrode is applied, a second electrode, and an organic layer stack within an active region of the substrate between the first and the second electrode, wherein the organic layer stack comprises at least one organic layer which is suitable for generating light, wherein the luminous means is arranged between two glass plates of the glazing of a window. Also, storage furniture is disclosed comprising a storage element shaped in planar fashion and having at least one storage surface and at least one radiation-emitting component, and at least one holding apparatus for holding the storage element.

Abstract: Organic light-emitting diodes as well as luminaires with such organic light-emitting diodes are specified. The luminaires may in particular be the following apparatuses, or the luminaires are part of existing apparatuses: alarm, shower cubicle, shower head, solar protection, rain protection, lamp, bed, signalling light, changing cubicle, vision protection, housing, emergency lighting, mirror, slabs, ceiling lights, radiator cladding, blinds, noise protection, umbrella, warning light.

Abstract: The present invention relates to pharmaceutical preparations and medicaments for intraarticular administration, comprising pepstatin, and to the preparation and use thereof, in particular in the treatment and/or prophylaxis of arthrosis, traumatic cartilage injuries, arthritis, pain, allodynia or hyperalgesia, particularly preferably in arthrosis.

Abstract: To integrate an inverter into a wireless local area communication network, wherein the inverter is connectable by its input to a local energy source and by its output to an AC mains, the inverter and a network access point of the wireless local area communication network are taken for a limited time period to an integration state in which the inverter joins the wireless local area communication network, wherein network access data pertaining to the wireless local area communication network are stored in a memory associated with the inverter, which network access data are used by said inverter to incorporate itself into the wireless local area communication network in future. In this case, the inverter is taken to its integration state by virtue of the mains voltage of the AC mains being applied to its output for the first time or again following an interruption.

Abstract: The present invention relates to compounds of the formula (I) and in particular to medicaments comprising at least one compound of the formula (I) for use in the treatment and/or prophylaxis of physiological and/or pathophysiological conditions in the triggering of which cathepsin D is involved, in particular for use in the treatment and/or prophylaxis of osteoarthritis, traumatic cartilage injuries, arthritis, pain, allodynia or hyperalgesia.

Abstract: The present invention relates to compounds of the formula I and in particular medicaments comprising at least one compound of the formula I for use in the treatment and/or prophylaxis of physiological and/or pathophysiological states in the triggering of which ADAMTS5 is involved, in particular for use in the treatment and/or prophylaxis of osteoarthritis, hepatocirrhosis, traumatic cartilage injuries, pain, allodynia or hyperalgesia.

Abstract: A method for producing an electronic component comprising barrier layers for the encapsulation of the component comprises, in particular, the following steps: providing a substrate with at least one functional layer, applying at least one first barrier layer on the functional layer via plasma enhanced atomic layer deposition (PEALD), and applying at least one second barrier layer on the functional layer by means of plasma-enhanced chemical vapor deposition (PECVD), where the at least one first barrier layer is applied at a temperature of less than 100° C.

Abstract: The present invention relates to compounds of the formula (I) and in particular to medicaments comprising at least one compound of the formula (I) for use in the treatment and/or prophylaxis of physiological and/or pathophysiological conditions in the triggering of which cathepsin D is involved, in particular for use in the treatment and/or prophylaxis of arthrosis, traumatic cartilage injuries arthritis, pain, allodynia or hyperalgesia.